NCT00125320View on ClinicalTrials.gov

Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Atrial FibrillationAtrial Flutter

Interventions

DRUG

RSD1235

Trial Locations (22)

2900

Hellerup

5000

Odense C

9000

Aalborg

33308

Fort Lauderdale

Unknown

Atlanta

Buenos Aires

La Plata

Warsaw

T2N 2T9

Calgary

M5B 1W8

Toronto

H2L 4M1

Montreal

H2W 1T8

Montreal

562 158

Bangalore

600 037

Chennai

500 001

Hyderabaad

682 026

Kerala

160 062

Mohali

400 051

Mumbai

110 025

New Delhi

40-635

Katowice

31-202

Krakow

91-425

Lodz

Sponsors

Lead Sponsor

Astellas Pharma Inc

Collaborators (1)

All Listed Sponsors

collaborator

Astellas Pharma US, Inc.

INDUSTRY

collaborator

Advanz Pharma

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00125320 - Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery | Biotech Hunter | Biotech Hunter